Torrent Pharma maintains strong credit ratings

Torrent Pharmaceuticals Limited informed stock exchanges on October 7, 2025, about the reaffirmation and assignment of credit ratings for its financial instruments.

ICRA Limited reaffirmed the long-term credit rating of the company's banking facilities and existing Non-Convertible Debentures (NCDs) at [ICRA] AA+ (Stable), assigned the same rating for proposed NCDs, and reaffirmed the credit rating for its Commercial Paper program at [ICRA] A1+.

Concurrently, India Ratings and Research Private Limited affirmed the credit rating for the company's existing banking facilities, issuer rating, and NCDs, and assigned a rating for the proposed NCDs. These ratings from India Ratings were affirmed/assigned at IND AA+(Stable), further underscoring the company's robust financial health.